AI-Discovered Treatment Keeps GitLab Founder Cancer-Free Since 2025

Sid Sijbrandij's AI-assisted cancer research team reportedly identified a personalized treatment that has kept him relapse-free, while new AI-designed molecules claim to boost chemotherapy effectiveness by 70%.

GitLab founder Sid Sijbrandij's unconventional bet on AI-driven cancer research appears to be paying off. As @VaibhavSisinty reported, Sijbrandij built a dedicated AI research team after his diagnosis, and the system identified a treatment that has kept him relapse-free since 2025. The specifics of the treatment protocol were not detailed in the post, but the trajectory — a tech founder applying AI to his own medical crisis and apparently succeeding — is a striking proof point for personalized AI-driven medicine.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum. Vestibulum ante ipsum primis in faucibus orci luctus et ultrices posuere cubilia curae.

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas. Proin pharetra nonummy pede. Mauris et orci. Aenean nec lorem. In porttitor. Donec laoreet nonummy augue. Suspendisse dui purus, scelerisque at, vulputate vitae, pretium mattis, nunc. Mauris eget neque at sem venenatis eleifend. Ut nonummy. Fusce aliquet pede non pede. Suspendisse dapibus lorem pellentesque magna integer malesuada.

Unlock the full briefing

Get every story in today's briefing, the full archive, and the daily AI intelligence brief.

All stories today

Full archive

Daily brief